Publicacións (180) Publicacións nas que participase algún/ha investigador/a

2022

  1. Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

    International journal of molecular sciences, Vol. 23, Núm. 17

  2. Antipsychotic-Associated Weight Gain and Clinical Improvement under Clozapine Treatment

    Journal of Clinical Psychopharmacology, Vol. 42, Núm. 1, pp. 75-80

  3. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

  4. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

  5. Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Frontiers in Psychiatry, Vol. 13

  6. Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study

    Journal of Affective Disorders, Vol. 298, pp. 58-64

  7. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 17

  8. Inteligencia emocional y síndrome de burnout en docentes de grado en enfermería de la Universidad de Vigo 2020

    III Congreso Interdisciplinar de Jóvenes Investigadores 23 y 24 de septiembre de 2021

  9. New Trends in Cognitive Aging and Mild Cognitive Impairment

    Geriatrics (Switzerland)

  10. Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

    Nanoscale, Vol. 14, Núm. 14, pp. 5488-5500

  11. Undetermined predominant polarity in a cohort of bipolar disorder patients: Prevalent, severe, and overlooked: Undetermined predominant polarity in bipolar disorder

    Journal of Affective Disorders, Vol. 303, pp. 223-229